Department of Pharmacology, School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
Molecules. 2022 May 27;27(11):3473. doi: 10.3390/molecules27113473.
Pseudoallergic reactions are hypersensitivity reactions mediated by an IgE-independent mechanism. Since allantoin (AT)-mediated pseudoallergy has not been studied, in this study, our objective is to investigate the anti-pseudoallergy effect of AT and its underlying mechanism. In vitro, β-hexosaminidase (β-Hex) and histamine (HIS) release assays, inflammatory cytokine assays, toluidine blue staining, and F-actin microfilament staining were used to evaluate the inhibitory effect of AT in RBL-2H3 cells stimulated with Compound 48/80 (C48/80). Western blot analysis is further performed to investigate intracellular calcium fluctuation-related signaling pathways. In vivo, Evans Blue extraction, paw swelling, and the diameter of Evans Blue extravasation were evaluated, and skin tissues are examined for histopathological examination in mice with passive cutaneous anaphylaxis (PCA) induced by C48/80. Body temperature is measured, and the levels of cytokines are further determined by ELISA kits in mice with active systemic anaphylaxis (ASA) induced by C48/80. The results show that AT dose-dependently inhibited degranulation in C48/80-stimulated RBL-2H3 cells by inhibiting β-Hex and HIS release, reducing the levels of TNF-α, IL-8, and MCP-1, inhibiting shape changes due to degranulation and disassembling the F-actin cytoskeleton. Furthermore, AT dose-dependently inhibits the phosphorylation of PLCγ and IP3R. In vivo, AT decreased Evans Blue extravasation, paw swelling, and the diameter of Evans Blue extravasation and significantly ameliorate pathological changes and mast cell degranulation in C48/80-induced PCA. Furthermore, AT help the mice recover from the C48/80-induced decrease in body temperature and decreased the levels of cytokines in C48/80-treated ASA mice. Our results indicate that allantoin inhibits compound 48/80-induced pseudoallergic reactions. AT has the potential to be used in IgE-independent anti-allergic and anti-inflammatory therapies.
假性过敏反应是一种由 IgE 非依赖性机制介导的超敏反应。由于尚未研究过尿囊素 (AT) 介导的假性过敏反应,因此在这项研究中,我们的目标是研究 AT 的抗假性过敏作用及其潜在机制。在体外,使用β-己糖胺酶 (β-Hex) 和组氨酸 (HIS) 释放测定、炎症细胞因子测定、甲苯胺蓝染色和 F-肌动蛋白微丝染色来评估 AT 对 C48/80 刺激的 RBL-2H3 细胞的抑制作用。进一步进行 Western blot 分析以研究细胞内钙波动相关信号通路。在体内,通过 C48/80 诱导的被动皮肤过敏反应 (PCA) 评估伊文思蓝提取、爪肿胀和伊文思蓝渗出的直径,并检查皮肤组织的组织病理学检查。通过 C48/80 诱导的主动全身性过敏反应 (ASA) 测量小鼠体温,并通过 ELISA 试剂盒进一步测定细胞因子水平。结果表明,AT 呈剂量依赖性抑制 C48/80 刺激的 RBL-2H3 细胞脱颗粒,通过抑制 β-Hex 和 HIS 释放,降低 TNF-α、IL-8 和 MCP-1 的水平,抑制脱颗粒引起的形态变化并分解 F-肌动蛋白细胞骨架。此外,AT 呈剂量依赖性抑制 PLCγ 和 IP3R 的磷酸化。在体内,AT 减少伊文思蓝渗出、爪肿胀和伊文思蓝渗出的直径,并显著改善 C48/80 诱导的 PCA 中的病理变化和肥大细胞脱颗粒。此外,AT 有助于 C48/80 处理的 ASA 小鼠从体温下降中恢复,并降低 C48/80 处理的 ASA 小鼠中的细胞因子水平。我们的结果表明,尿囊素抑制化合物 48/80 诱导的假性过敏反应。AT 有可能用于 IgE 非依赖性抗过敏和抗炎治疗。